Posts

AZD-9550 by AstraZeneca for Metabolic Dysfunction-Assoc...

Dec 26, 2023

AZD-9550 is under clinical development by AstraZeneca and currently in Phase I f...

GS-4528 by Gilead Sciences for Metastatic Renal Cell Ca...

Dec 26, 2023

GS-4528 is under clinical development by Gilead Sciences and currently in Phase ...

ADRX-0706 by Adcentrx Therapeutics for Head And Neck Sq...

Dec 26, 2023

ADRX-0706 is under clinical development by Adcentrx Therapeutics and currently i...

BGB-30813 by BeiGene for Head And Neck Squamous Cell Ca...

Dec 26, 2023

BGB-30813 is under clinical development by BeiGene and currently in Phase I for ...

NT-175 by Neogene Therapeutics for Head And Neck Squamo...

Dec 26, 2023

NT-175 is under clinical development by Neogene Therapeutics and currently in Ph...

ORB-011 by Orionis Biosciences for Head And Neck Squamo...

Dec 26, 2023

ORB-011 is under clinical development by Orionis Biosciences and currently in Ph...

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

Dec 26, 2023

ODM-212 is under clinical development by Orion and currently in Phase I for Soli...

KB-707 by Krystal Biotech for Solid Tumor: Likelihood o...

Dec 26, 2023

KB-707 is under clinical development by Krystal Biotech and currently in Phase I...

RO-7566802 by Genentech USA for Solid Tumor: Likelihood...

Dec 26, 2023

RO-7566802 is under clinical development by Genentech USA and currently in Phase...

AWT-020 by Anwita Biosciences for Sarcomas: Likelihood ...

Dec 26, 2023

AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...

STAT+: The clock is ticking, and Cytokinetics is running out of December

STAT+: The clock is ticking, and Cytokinetics is runnin...

Dec 25, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Health data breaches hit an all-time high in 2023

STAT+: Health data breaches hit an all-time high in 2023

Dec 25, 2023

At least 116 million individuals were impacted by large and numerous health data...

STAT+: BioMarin appeases an activist

STAT+: BioMarin appeases an activist

Dec 25, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

Unraveling the mystery of hereditary diffuse gastric cancer

Unraveling the mystery of hereditary diffuse gastric ca...

Dec 25, 2023

Gastric cancer, a significant global health burden, claims over 7% of cancer-rel...

Electronic “soil” enhances crop growth

Electronic “soil” enhances crop growth

Dec 25, 2023

Barley seedlings grow on average 50% more when their root system is stimulated e...

Devimistat by Cornerstone Pharmaceuticals for Soft Tiss...

Dec 24, 2023

Devimistat is under clinical development by Cornerstone Pharmaceuticals and curr...